Augmedix, Inc.
AUGX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $44,855 | $30,933 | $22,165 | $16,483 |
| % Growth | 45% | 39.6% | 34.5% | – |
| Cost of Goods Sold | $23,329 | $16,979 | $12,158 | $9,689 |
| Gross Profit | $21,526 | $13,954 | $10,007 | $6,794 |
| % Margin | 48% | 45.1% | 45.1% | 41.2% |
| R&D Expenses | $11,176 | $10,149 | $6,678 | $4,522 |
| G&A Expenses | $18,442 | $16,893 | $13,759 | $11,567 |
| SG&A Expenses | $29,129 | $26,176 | $21,267 | $15,965 |
| Sales & Mktg Exp. | $10,687 | $9,283 | $7,508 | $4,398 |
| Other Operating Expenses | $0 | $0 | $87 | $0 |
| Operating Expenses | $40,305 | $36,325 | $27,945 | $20,487 |
| Operating Income | -$18,779 | -$22,371 | -$17,938 | -$13,693 |
| % Margin | -41.9% | -72.3% | -80.9% | -83.1% |
| Other Income/Exp. Net | -$247 | -$1,967 | $134 | -$1,911 |
| Pre-Tax Income | -$19,026 | -$24,449 | -$17,851 | -$15,604 |
| Tax Expense | $145 | $0 | -$691 | $0 |
| Net Income | -$19,171 | -$26,527 | -$17,160 | -$14,737 |
| % Margin | -42.7% | -85.8% | -77.4% | -89.4% |
| EPS | -0.44 | -0.71 | -0.59 | -0.56 |
| % Growth | 38% | -20.3% | -5.4% | – |
| EPS Diluted | -0.44 | -0.71 | -0.59 | -0.55 |
| Weighted Avg Shares Out | 43,946 | 37,418 | 28,915 | 26,246 |
| Weighted Avg Shares Out Dil | 43,946 | 37,418 | 28,915 | 26,864 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,110 | $245 | $15 | $11 |
| Interest Expense | $2,253 | $1,675 | $2,252 | $1,453 |
| Depreciation & Amortization | $1,098 | $1,528 | $691 | $867 |
| EBITDA | -$15,675 | -$21,807 | -$14,474 | -$13,284 |
| % Margin | -34.9% | -70.5% | -65.3% | -80.6% |